Keith Houser - Biotech Medics Chairman Pres

BMCS Stock  USD 0.02  0.00  0.00%   

Insider

Keith Houser is Chairman Pres of Biotech Medics Ne
Age 74
Phone972-274-5533
Webhttps://biotecmedics.com

Similar Executives

Showing other executives

INSIDER Age

CSC MDShuttle Pharmaceuticals
57
Ken GelhausAlpha Teknova
40
Paul BlanchfieldLantheus Holdings
44
Adel MekhailPrestige Brand Holdings
64
Alexander SchobelAquestive Therapeutics
66
David FranciscoOrganogenesis Holdings
59
Albert BollesLifecore Biomedical
67
Muthusamy RPhANI Pharmaceuticals
57
Mira JungShuttle Pharmaceuticals
76
Dean SiegalPrestige Brand Holdings
N/A
Meg SmithDynavax Technologies
N/A
CPA CPAIntracellular Th
68
Jean FilippiPhibro Animal Health
N/A
Peter LangoshAmphastar P
71
Eric DadeyAquestive Therapeutics
N/A
Floyd MDAlkermes Plc
88
Zorina PitkinOrganogenesis Holdings
N/A
Yongfeng ZhangAmphastar P
78
Jude OnyiaNeurocrine Biosciences
61
Damian FinioPhibro Animal Health
54
Patrick BilboOrganogenesis Holdings
63
BioTech Medics, Inc. operates as a medical-based holding company. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Biotech Medics is traded on OTC Exchange in the United States. Biotech Medics Ne [BMCS] is a Pink Sheet which is traded between brokers over the counter.

Biotech Medics Ne Leadership Team

Elected by the shareholders, the Biotech Medics' board of directors comprises two types of representatives: Biotech Medics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotech. The board's role is to monitor Biotech Medics' management team and ensure that shareholders' interests are well served. Biotech Medics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotech Medics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Keith Houser, Chairman Pres
James Nairne, Chief Officer
Anthony Miller, Chief Officer
Tom Wood, VP Sales

Biotech Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Biotech Medics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Biotech Pink Sheet Analysis

When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.